chr2-104855624-CGGCGGCGGG-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_006236.3(POU3F3):c.122_130delGGGGCGGCG(p.Gly41_Gly43del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000171 in 758,138 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000037 ( 0 hom., cov: 6)
Exomes 𝑓: 0.000015 ( 0 hom. )
Consequence
POU3F3
NM_006236.3 disruptive_inframe_deletion
NM_006236.3 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.65
Genes affected
POU3F3 (HGNC:9216): (POU class 3 homeobox 3) This gene encodes a POU-domain containing protein that functions as a transcription factor. The encoded protein recognizes an octamer sequence in the DNA of target genes. This protein may play a role in development of the nervous system. [provided by RefSeq, Apr 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 2-104855624-CGGCGGCGGG-C is Benign according to our data. Variant chr2-104855624-CGGCGGCGGG-C is described in ClinVar as [Likely_benign]. Clinvar id is 2358994.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POU3F3 | NM_006236.3 | c.122_130delGGGGCGGCG | p.Gly41_Gly43del | disruptive_inframe_deletion | 1/1 | ENST00000361360.4 | NP_006227.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POU3F3 | ENST00000361360.4 | c.122_130delGGGGCGGCG | p.Gly41_Gly43del | disruptive_inframe_deletion | 1/1 | 6 | NM_006236.3 | ENSP00000355001.2 |
Frequencies
GnomAD3 genomes AF: 0.0000367 AC: 3AN: 81704Hom.: 0 Cov.: 6
GnomAD3 genomes
AF:
AC:
3
AN:
81704
Hom.:
Cov.:
6
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000148 AC: 10AN: 676436Hom.: 0 AF XY: 0.00000956 AC XY: 3AN XY: 313718
GnomAD4 exome
AF:
AC:
10
AN:
676436
Hom.:
AF XY:
AC XY:
3
AN XY:
313718
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000367 AC: 3AN: 81702Hom.: 0 Cov.: 6 AF XY: 0.0000508 AC XY: 2AN XY: 39368
GnomAD4 genome
AF:
AC:
3
AN:
81702
Hom.:
Cov.:
6
AF XY:
AC XY:
2
AN XY:
39368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 02, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at